REGENERATE-COBRA: A phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angina. - Ramaseshan R; Perera D; Reid A; Andiapen M; Ariti C; Kelham M; Jones DA; Mathur A (American heart journal, 2024)